Margin involvement at prostatectomy for clinically localized prostate cancer: does a low-risk group exist?

Area of Science:

• Urologic Oncology
• Pathology
• Surgical Outcomes

Background:

• Radical prostatectomy (RP) is a primary treatment for prostate cancer.
• Surgical margin status after RP is a key prognostic factor.
• Further stratification of risk in patients with involved margins is needed.

Purpose of the Study:

• To evaluate if detailed pathology findings can improve risk stratification for patients with involved surgical margins after RP.
• To identify specific pathological features associated with biochemical recurrence (PSA relapse).

Main Methods:

• Retrospective analysis of 279 patients who underwent RP between 2003-2010.
• Exclusion criteria included high PSA, short follow-up, nodal/seminal vesicle involvement, or prior adjuvant therapy.
• Pathology specimens were reviewed by a blinded pathologist; survival analysis was used to assess outcomes.

Main Results:

• Patients with involved surgical margins had a significantly higher rate of PSA relapse (27%) compared to those with negative margins (4%).
• Detailed pathology review revealed associations between PSA relapse and Gleason score, margin width, capsular penetration, and perineural invasion.
• A subgroup of patients with Gleason score ≤6 and margin width ≤4 mm showed a low 5-year PSA relapse rate (4%); higher Gleason or wider margins indicated >20% risk.

Conclusions:

• Gleason score and margin width are critical factors for predicting early PSA relapse after RP, even with margin involvement.
• Low-grade prostate cancer with limited margin involvement has a favorable prognosis.
• High-grade disease or extensive margin involvement portends a higher risk of early recurrence.